CV Sciences, Inc. Announces Brand Brand New Distribution With Kroger and Expands Its Providing of Topical Products
PlusCBD™ Oil Roll-On Launch at 945 Kroger shops in 17 U.S. States
LAS VEGAS, NEVADA, June 12, 2019 (WORLD NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent provider and maker of hemp CBD items, is very happy to announce further expansion of the industry-dominating PlusCBD™ Oil brand name utilizing the Kroger Co. (NYSE:KR).
The Company’s expanded retail circulation includes the launch of CV Sciences’ new PlusCBD Oil™ Roll-Ons in 945 Kroger shops across lots of its retail ads, including Kroger, Dillons, Fry’s, Fred Meyer, King Sooper, Mariano’s, Pick ‘n Save, QFC and Smiths areas in 17 U.S. states. PlusCBD™ Oil Roll-On, for sale in 200mg CBD and additional Strength 500mg formulations, is infused with concentrated CBD from agricultural hemp plant parts, warming camphor and cooling menthol. https://cbdoilrating.net Made out of its Gold Formula focused complete range hemp extract, the Roll-Ons offer high strength help within an application that is easy-to-use. The Company’s best-selling PlusCBD™ Oil Extra Strength and Original Balms can also be found at the participating Kroger areas. All PlusCBD™ Oil topical products contain no phthalates, sulfates or parabens and are made without artificial dyes or scents to meet consumer expectations of clean ingredients.
As talked about regarding the Company’s first quarter 2019 profits turn to May 8, 2019, CV Sciences’ recent circulation gains include option of PlusCBD™ Oil Extra Strength Balm in a preliminary launch at CVS Pharmacy shops. By adding 945 Kroger areas and brand new circulation into other leading Food, Drug and Mass (FDM) stores, at the time of June 12, 2019, PlusCBD™ Oil branded items are for sale in 4,591 stores, up from 3,308 stores at the time of March 31, 2019, a rise of 38.7% throughout the prior 8 weeks.
“We are pleased to partner with Kroger and introduce our brand new Roll-On topical as we continue our fast expansion in to the FDM channel,” said Joseph Dowling, Chief Executive Officer. “Kroger, CVS Pharmacy, and other leading national retailers are keenly conscious of the increased customer need for hemp-based CBD items and they’re partnering with CV Sciences as a result of our unwavering dedication to security and quality. We have been at the start of everything we think would be acceptance that is broad of products across national FDM records and we also enjoy our continued development even as we expand shop count and SKUs with this retail lovers.”
PlusCBD™ Oil Extra Strength Balm ranks #1 in product sales both in the Total U.S. Natural Channel and complete U.S. MULO (Multi Outlet) throughout the last 52 months* among CBD services and products within Topical Analgesics, according to SPINS and IRI information, correspondingly. Brightfield Group, a respected predictive analytics and researching the market company when it comes to CBD market, expects $1.3 billion in product sales of CBD topicals in 2019, by having an ingredient yearly development price of 169% from 2018 – 2022.
About CV Sciences, Inc.
CV Sciences, Inc. (OTCQB:CVSI) runs two distinct company sections: a customer item unit centered on production, advertising and attempting to sell plant-based CBD items to a selection of market sectors; and a medication development unit focused on developing and commercializing CBD-based novel therapeutics using CBD. The Company’s PlusCBD™ Oil may be the top-selling model of hemp-derived CBD in the marketplace, relating to SPINS, the key provider of syndicated information and insights for the normal, natural and specialty products industry. CV Sciences, Inc. has offices that are primary facilities in north park, Ca and Las vegas, nevada, Nevada. Extra information can be acquired from OTCMarkets.com or by visiting www.cvsciences.com.
This pr release may contain specific forward-looking statements and information, as defined in the concept of Section 27A of this Securities Act of 1933 and Section 21E of this Securities Exchange Act of 1934, and it is at the mercy of the secure Harbor developed by those parts. This product contains statements about anticipated future activities and/or monetary outcomes which are forward-looking in the wild and at the mercy of dangers and uncertainties. Such forward-looking statements by meaning incorporate risks, uncertainties.